Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease. [electronic resource]
Producer: 20150409Description: 5031-5 p. digitalISSN:- 2219-2840
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents -- adverse effects
- Antibodies -- blood
- Antibodies, Monoclonal -- adverse effects
- Biomarkers -- blood
- Case-Control Studies
- Drug Hypersensitivity -- blood
- Drug Monitoring
- Female
- Humans
- Inflammatory Bowel Diseases -- blood
- Infliximab
- Male
- Middle Aged
- Predictive Value of Tests
- Prospective Studies
- Remission Induction
- Risk Factors
- Treatment Failure
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.